ArriVent BioPharma, Inc Common Stock
Price & Volume
Stats
See moreOpen | $13.42 |
Previous Close | $13.02 |
Day Range | $12.50-$13.56 |
52W Range | $11.36-$35.83 |
Market Cap | $658.2M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.25 |
News
See moreYahoo Finance • 2 days ago
Aarvik Therapeutics Announces Milestone Achievement, Partnership Update, and Presentations on MUTTA™ and AQUALINK™ Platforms at the 17th Annual WADC Conference
Yahoo Finance • 4 months ago
Citi's picks and pans for H2 '26: REITs, tech, consumer, health
Yahoo Finance • 6 months ago
ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers
Yahoo Finance • 6 months ago
Noteworthy Thursday Option Activity: AVBP, VIAV, ASTS
About
CEO | Dr. Zhengbin Yao Ph.D. |
CFO | Mr. Winston Kung M.B.A. |
Address | 18 Campus Boulevard, Newtown Square, PA, United States, 19073 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 77 |